3D spheroids of human placenta-derived mesenchymal stem cells attenuate spinal cord injury in mice.
Ontology highlight
ABSTRACT: Mesenchymal stem cell (MSC) is an absorbing candidate for cell therapy in treating spinal cord injury (SCI) due to its great potential for multiple cell differentiation, mighty paracrine secretion as well as vigorous immunomodulatory effect, of which are beneficial to the improvement of functional recovery post SCI. However, the therapeutic effects of MSC on SCI have been limited because of the gradual loss of MSC stemness in the process of expanding culture. Therefore, in this study, we aimed to maintain those beneficial properties of MSC via three-dimensional spheroid cell culture and then compared them with conventionally-cultured MSCs in the treatment of SCI both in vitro and in vivo with the aid of two-photon microscope. We found that 3D human placenta-derived MSCs (3D-HPMSCs) demonst
SUBMITTER: Deng J
PROVIDER: S-EPMC8606575 | biostudies-literature | 2021 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA